Download Free Sample Report

CAR-T Therapy Market, Global Outlook and Forecast 2023-2032

CAR-T Therapy Market, Global Outlook and Forecast 2023-2032

  • Published on : 05 October 2023
  • Pages :63
  • Report Code:SMR-7824209

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

This report aims to provide a comprehensive presentation of the global market for CAR-T Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Therapy. This report contains market size and forecasts of CAR-T Therapy in global, including the following market information:
Global CAR-T Therapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global CAR-T Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
CD19 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of CAR-T Therapy include Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech and Atara Biotherapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the CAR-T Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CAR-T Therapy Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global CAR-T Therapy Market Segment Percentages, by Type, 2022 (%)
CD19
CD22
Other
Global CAR-T Therapy Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global CAR-T Therapy Market Segment Percentages, by Application, 2022 (%)
Acute Lymphocytic Leukemia
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Chronic Lymphocytic Leukemia
Multiple Myeloma
Other
Global CAR-T Therapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global CAR-T Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CAR-T Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CAR-T Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Kite Pharma
Pfizer
Juno Therapeutics
Celgene Corporation
CARsgen Therapeutics
Sorrento Therapeutics
Legend Biotech
Atara Biotherapeutics
Aurora Biopharma
Autolus Therapeutics PLC
Bluebird
Carina Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of CAR-T Therapy, market overview.
Chapter 2: Global CAR-T Therapy market size in revenue.
Chapter 3: Detailed analysis of CAR-T Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CAR-T Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.